^ abc“Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex”. FEBS Lett.448 (1): 185–9. (April 1999). doi:10.1016/S0014-5793(99)00367-1. PMID 10217437.
^ ab“Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1”. J. Biol. Chem.274 (15): 10618–24. (April 1999). doi:10.1074/jbc.274.15.10618. PMID 10187858.
^ ab“Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1”. EMBO J.24 (3): 439–51. (February 2005). doi:10.1038/sj.emboj.7600552. PMC 548657. PMID 15660128. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548657/.
^“Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8”. Nature422 (6929): 330–4. (March 2003). Bibcode: 2003Natur.422..330W. doi:10.1038/nature01456. PMID 12646924.
^“SP-RING for SUMO: new functions bloom for a ubiquitin-like protein”. Cell107 (1): 5–8. (October 2001). doi:10.1016/S0092-8674(01)00519-0. PMID 11595179.
^“SUMO-1 modification activates the transcriptional response of p53”. EMBO J.18 (22): 6455–61. (November 1999). doi:10.1093/emboj/18.22.6455. PMC 1171708. PMID 10562557. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1171708/.
^“Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2”. Curr. Biol.8 (2): 121–4. (January 1998). doi:10.1016/S0960-9822(98)70044-2. PMID 9427648.
^“Expression and regulation of the mammalian SUMO-1 E1 enzyme”. FASEB J.15 (10): 1825–7. (August 2001). doi:10.1096/fj.00-0818fje. PMID 11481243.
^“A conditional knockout resource for the genome-wide study of mouse gene function”. Nature474 (7351): 337–42. (2011). doi:10.1038/nature10163. PMC 3572410. PMID 21677750. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572410/.
^“Mouse library set to be knockout”. Nature474 (7351): 262–3. (2011). doi:10.1038/474262a. PMID 21677718.
^“A mouse for all reasons”. Cell128 (1): 9–13. (2007). doi:10.1016/j.cell.2006.12.018. PMID 17218247.
^ abcGerdin AK (2010). “The Sanger Mouse Genetics Programme: High throughput characterisation of knockout mice”. Acta Ophthalmologica88: 925–7. doi:10.1111/j.1755-3768.2010.4142.x.
^“The mouse genetics toolkit: revealing function and mechanism”. Genome Biol.12 (6): 224. (2011). doi:10.1186/gb-2011-12-6-224. PMC 3218837. PMID 21722353. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218837/.
^“Identification and characterisation of the Drosophila homologue of the yeast Uba2 gene”. Biochim. Biophys. Acta1518 (1–2): 210–4. (March 2001). doi:10.1016/S0167-4781(01)00185-3. PMID 11267682.
^“Towards a proteome-scale map of the human protein-protein interaction network”. Nature437 (7062): 1173–8. (October 2005). Bibcode: 2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514.
^ ab“Large-scale mapping of human protein-protein interactions by mass spectrometry”. Mol. Syst. Biol.3 (1): 89. (2007). doi:10.1038/msb4100134. PMC 1847948. PMID 17353931. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1847948/.
^“Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation”. Biochemistry42 (33): 9959–69. (August 2003). doi:10.1021/bi0345283. PMID 12924945.
“The nucleoporin RanBP2 has SUMO1 E3 ligase activity”. Cell108 (1): 109–20. (2002). doi:10.1016/S0092-8674(01)00633-X. PMID 11792325.
“A mechanism for inhibiting the SUMO pathway”. Mol. Cell16 (4): 549–61. (2004). doi:10.1016/j.molcel.2004.11.007. PMID 15546615.
“A human protein-protein interaction network: a resource for annotating the proteome”. Cell122 (6): 957–68. (2005). doi:10.1016/j.cell.2005.08.029. hdl:11858/00-001M-0000-0010-8592-0. PMID 16169070.
“A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers”. Arch. Biochem. Biophys.453 (1): 70–4. (2006). doi:10.1016/j.abb.2006.03.002. PMID 16620772. https://zenodo.org/record/1258674.
“Towards a proteome-scale map of the human protein-protein interaction network”. Nature437 (7062): 1173–8. (2005). Bibcode: 2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514.
“Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design”. Proc. Natl. Acad. Sci. U.S.A.108 (19): 7751–6. (2011). Bibcode: 2011PNAS..108.7751G. doi:10.1073/pnas.1102294108. PMC 3093456. PMID 21518904. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093456/.
“Importin α/β mediates nuclear import of individual SUMO E1 subunits and of the holo-enzyme”. Mol. Biol. Cell22 (5): 652–60. (2011). doi:10.1091/mbc.E10-05-0461. PMC 3046061. PMID 21209321. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046061/.
“Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes”. Mol. Cell21 (3): 349–57. (2006). doi:10.1016/j.molcel.2005.12.019. PMID 16455490.
“Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1”. EMBO J.24 (3): 439–51. (2005). doi:10.1038/sj.emboj.7600552. PMC 548657. PMID 15660128. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548657/.
“Expression and regulation of the mammalian SUMO-1 E1 enzyme”. FASEB J.15 (10): 1825–7. (2001). doi:10.1096/fj.00-0818fje. PMID 11481243.
“CGI-55 interacts with nuclear proteins and co-localizes to p80-coilin positive-coiled bodies in the nucleus”. Cell Biochem. Biophys.44 (3): 463–74. (2006). doi:10.1385/CBB:44:3:463. PMID 16679534.
“APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication”. Retrovirology5: 72. (2008). doi:10.1186/1742-4690-5-72. PMC 2535603. PMID 18680593. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2535603/.
“Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation”. Biochemistry42 (33): 9959–69. (2003). doi:10.1021/bi0345283. PMID 12924945.
“Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A.101 (33): 12130–5. (2004). Bibcode: 2004PNAS..10112130B. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC514446/.